Sponsor or institution
Clinical trials and research at Pop Biotechnologies, INC
As of November 12, 2026, Find a Trial lists 11 NIH-funded research projects at this institution, with $6.6 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 11NIH research projects
NIH-funded research (11)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Multivalent tau and Aβ vaccine on SNAP liposomes for Alzheimer’s disease
A new vaccine approach aims to train the immune system to target multiple Alzheimer’s disease proteins at once, potentially slowing or preventing progression in people at risk.
-
A targeted immune therapy against artery disease using a liposome-linked ApoB fragment
A first-in-class approach aims to train the immune system to fight atherosclerosis by using a tiny ApoB fragment displayed on a liposome to elicit a protective immune response.
-
Advanced mosaic influenza vaccine platform to protect people faster and with fewer doses
A new vaccine approach uses a nanoparticle platform to deliver multiple flu antigens together, aiming to provide strong protection with smaller doses and quicker deployment.
-
Vaccine that targets several amyloid (Aβ) and tau pieces for Alzheimer's
This project is making a vaccine that trains the immune system to target both amyloid and tau proteins to help people at risk for or living with Alzheimer's disease.
-
Peptide vaccine to prevent serious Candida bloodstream infections, including drug‑resistant C. auris
This project develops a liposome-based peptide vaccine intended to help protect hospitalized and immunocompromised people from life-threatening Candida bloodstream infections, including drug‑resistant C. auris.
-
Testing a new influenza vaccine that uses less antigen and can be deployed quickly.
This study is testing a new type of flu vaccine that uses tiny particles to boost your immune response, so you can get better protection against different flu strains with smaller doses, making it easier to use during outbreaks.
-
Vaccine to fight serious Candida infections
This study is working on a new vaccine to help protect people, especially those with weakened immune systems, from serious bloodstream infections caused by tough-to-treat fungi like C. auris, with the hope that it can make these infections less severe and less frequent.
-
Developing a new influenza vaccine using plant-derived nanoparticles
This study is testing a new flu vaccine made from a plant ingredient and tiny particles to see if it can help your body fight off different types of the flu better, and it's being done first in animals like mice and ferrets before it can be used in people.
-
Developing a vaccine to target multiple proteins involved in Alzheimer's disease
This study is working on a new vaccine that could help fight Alzheimer's disease by training the immune system to target specific proteins linked to the condition, and it's being tested in mice that have a similar brain setup to humans, with hopes that it could lead to better treatments for people with Alzheimer's.
-
New treatment for advanced liver cancer using light-activated nanoparticles
This study is testing a new treatment for people with advanced liver cancer that combines a special chemotherapy drug with laser light to help target the tumor more effectively and reduce side effects.
-
Using light-activated nanoparticles to treat liver cancer
This study is testing a new way to treat hard-to-treat liver cancers by using special nanoparticles that release a chemotherapy drug when activated by laser light, and it's designed for patients with locally advanced liver cancer.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.